Company press releases
Tid | Selskap | Tittel | Sektor | Kategori |
---|---|---|---|---|
03 Mar 2023 09:16 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Invitation to extended fourth quarter presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
03 Mar 2023 09:16 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Invitation to extended fourth quarter presentation | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
15 Feb 2023 20:28 CET |
SOFTOX SOLUTIONS | Softox Solutions AS: Q4 2022 Results. Challenging liquidity situation and other company updates | 20103010 Biotechnology | Inside information |
15 Feb 2023 20:28 CET |
SOFTOX SOLUTIONS | Softox Solutions AS: Q4 2022 Results. Challenging liquidity situation and other company updates | 20103010 Biotechnology | Innsideinformasjon |
09 Jan 2023 07:30 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Final grant agreement with the European Defence Fund signed | 20103010 Biotechnology | Non-regulatory press releases |
09 Jan 2023 07:30 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Final grant agreement with the European Defence Fund signed | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
29 Dec 2022 10:17 CET |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
20 Dec 2022 08:36 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Announces organizational changes | 20103010 Biotechnology | Inside information |
15 Dec 2022 09:09 CET |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: FINAL REPORT REAFFIRMS POSITIVE TOP LINE PHASE 1 RESULTS FOR SOFTOX BIOFILM ERADICATOR | 20103010 Biotechnology | Non-regulatory press releases |
09 Dec 2022 13:11 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Minutes from extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
02 Dec 2022 11:03 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Notice of Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
03 Nov 2022 14:07 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Mandatory notification for close associate | 20103010 Biotechnology | Inside information |
26 Oct 2022 07:00 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS: THIRD QUARTER 2022 RESULTS | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
24 Oct 2022 19:58 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Invitation to the presentation of the Q3 2022 results | 20103010 Biotechnology | Non-regulatory press releases |
19 Oct 2022 07:32 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Approval from the Swedish Chemicals Agency on disinfection products received | 20103010 Biotechnology | Inside information |
18 Oct 2022 15:15 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Minutes from extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
11 Oct 2022 13:30 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Mandatory notification for close associate | 20103010 Biotechnology | Inside information |
11 Oct 2022 09:14 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Raises 25 MNOK in new secured convertible loan and calls for extraordinary general meeting | 20103010 Biotechnology | Inside information |
04 Oct 2022 14:49 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Received final assessment draft from the Swedish Chemicals Agency on disinfection products | 20103010 Biotechnology | Non-regulatory press releases |
04 Oct 2022 08:11 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: POSITIVE TOP LINE PHASE 1 RESULTS FOR SOFTOX BIOFILM ERADICATOR - UPDATE ON THE COMPANY’S FINANCIAL SITUATION | 20103010 Biotechnology | Inside information |
05 Sep 2022 07:18 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Announces the end of the SBE Phase 1 clinical study for treatment of chronic wounds | 20103010 Biotechnology | Non-regulatory press releases |
01 Sep 2022 08:29 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Strengthens its leadership team | 20103010 Biotechnology | Non-regulatory press releases |
15 Aug 2022 07:00 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: SECOND QUARTER AND HALF YEAR RESULTS | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
11 Aug 2022 08:37 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Invitation to the presentation of the 2Q 2022 results (update) | 20103010 Biotechnology | Non-regulatory press releases |
08 Aug 2022 11:55 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Invitation to the presentation of the 2Q 2022 results | 20103010 Biotechnology | Non-regulatory press releases |
08 Aug 2022 07:54 CEST |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
20 Jul 2022 00:03 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Granted NOK 97 million from the European Defence Fund for the development of an inhalation solution countering CBRN -threats | 20103010 Biotechnology | Inside information |
28 Jun 2022 15:11 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Clinical trial data published in Acta Dermato-Venereologica | 20103010 Biotechnology | Non-regulatory press releases |
28 Jun 2022 07:59 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Strengthens the liquidity | 20103010 Biotechnology | Inside information |
13 Jun 2022 15:37 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS notes the Norwegian Defence Research Establishment’s (FFI) positive data analysis of non-alcohol disinfectants | 20103010 Biotechnology | Non-regulatory press releases |
19 May 2022 10:30 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: ANNOUNCES POSITIVE PHASE 1 RESULTS FOR SOFTOX INHALATION SOLUTION (SIS) | 20103010 Biotechnology | Inside information |
18 May 2022 15:06 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: to attend and host an educational symposium at the European Wound Management Association Conference | 20103010 Biotechnology | Non-regulatory press releases |
12 May 2022 13:56 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Annual general meeting held | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
11 May 2022 07:30 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: The SBE-01 phase 1 clinical study enters the final phase 1b | 20103010 Biotechnology | Non-regulatory press releases |
05 May 2022 14:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
04 May 2022 17:31 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Annual Report 2021 | 20103010 Biotechnology | Annual financial and audit Reports |
28 Apr 2022 13:15 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Announces advancement into next phase (1b) in the SBE project | 20103010 Biotechnology | Non-regulatory press releases |
28 Apr 2022 07:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Results for the first quarter of 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
21 Apr 2022 16:16 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Invitation to the presentation of the 1Q 2022 results | 20103010 Biotechnology | Non-regulatory press releases |
19 Apr 2022 07:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Announces completion of last subject last visit in SIS project | 20103010 Biotechnology | Non-regulatory press releases |
16 Feb 2022 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Results for the fourth quarter 2021 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
15 Feb 2022 11:36 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Postponed webcast presentation of Q4 2021 results | 20103010 Biotechnology | Non-regulatory press releases |
08 Feb 2022 15:28 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Invitation to the presentation of the 4Q 2021 results | 20103010 Biotechnology | Non-regulatory press releases |
31 Jan 2022 08:04 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Beholder desinfeksjon for hånd og overflate i markedet | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
28 Jan 2022 17:23 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Mottatt svar fra Miljødirektoratet | 20103010 Biotechnology | Innsideinformasjon |
24 Jan 2022 09:53 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Endring vedrørende søknad om nasjonal godkjennelse for desinfeksjonsprodukter | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
24 Jan 2022 09:53 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Changes regarding application for national approval of disinfection products | 20103010 Biotechnology | Non-regulatory press releases |
24 Jan 2022 08:00 CET |
SOFTOX SOLUTIONS | SOFTOX BIOFILM ERADICATOR STUDY (SBE-01) ADVANCES TO NEXT DOSE LEVEL DUE TO EXCELLENT SAFETY IN THE TREATMENT OF CHRONIC WOUNDS | 20103010 Biotechnology | Non-regulatory press releases |
17 Jan 2022 16:10 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Cancellation of subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
01 Jan 2022 16:20 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |